In the last trading session, 2.5 million shares of the Neogenomics Inc (NASDAQ:NEO) were traded, and its beta was 1.63. Most recently the company’s share price was $7.69, and it changed around -$0.15 or -1.91% from the last close, which brings the market valuation of the company to $989.66M. NEO currently trades at a discount to its 52-week high of $19.11, offering almost -148.5% off that amount. The share price’s 52-week low was $6.08, which indicates that the current value has risen by an impressive 20.94% since then.
Neogenomics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.80. If we narrow it down even further, the data shows that 0 out of 14 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 5 recommended NEO as a Hold, whereas 6 deemed it a Buy, and 0 rated it as Underweight.
Neogenomics Inc (NASDAQ:NEO) trade information
Instantly NEO has showed a red trend with a performance of -1.91% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 8.24 on recent trading dayincreased the stock’s daily price by 6.67%. The company’s shares are currently down -53.34% year-to-date, but still up 16.87% over the last five days. On the other hand, Neogenomics Inc (NASDAQ:NEO) is -12.41% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $15, which translates to bulls needing to increase their stock price by 48.73% from its current value. Analyst projections state that NEO is forecast to be at a low of $12 and a high of $18.
Neogenomics Inc earnings are expected to increase by 38.18% in 2025, but the outlook is positive 66.44% per year for the next five years.
NEO Dividends
Neogenomics Inc’s next quarterly earnings report is expected to be released in June.
VANGUARD GROUP INC, with 11.1716% or 14.12 million shares worth $195.87 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 7.94 shares worth $61.03 million, making up 6.17% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 3.95 shares worth around $30.39 million, which represents about 3.07% of the total shares outstanding.
